<span item_type="fundamental" item_id="79af357987c6ff4a67ded634f3900b56" counter_id="ST/US/TDAC" env="prod"></span><span item_type="announcement" item_id="518503919660634881" env="prod"></span><p>Revenue: As of FY2025 Q1, the actual value is USD 223.85 K.</p><p>EPS: As of FY2025 Q1, the actual value is USD -0.14.</p><p>EBIT: As of FY2025 Q1, the actual value is USD -3.48 M.</p><p></p><h3>Segment Revenue</h3><ul><li>Revenue for the three months ended March 31, 2025 was $223,849, a decrease of $35,470 or 14% compared to $259,319 for the three months ended March 31, 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1673481/000164117225011865/form10-q.htm"></span></li></ul><h3>Operational Metrics</h3><ul><li>Gross profit for the three months ended March 31, 2025 was $61,381 compared to $175,532 for the three months ended March 31, 2024, a decrease of $114,151 or 65%.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1673481/000164117225011865/form10-q.htm"></span></li><li>Loss from operations for the three months ended March 31, 2025 was -$3,479,982 compared to -$5,594,829 for the three months ended March 31, 2024, a decrease of $2,114,847 or 38%.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1673481/000164117225011865/form10-q.htm"></span></li><li>Net loss for the three months ended March 31, 2025 was -$3,295,020 compared to -$5,753,872 for the three months ended March 31, 2024, a decrease of $2,458,852 or 43%.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1673481/000164117225011865/form10-q.htm"></span></li></ul><h3>Cash Flow</h3><ul><li>Net cash used in operating activities was $924,900 for the three months ended March 31, 2025, compared to net cash used in operating activities of -$1,077,990 for the three months ended March 31, 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1673481/000164117225011865/form10-q.htm"></span></li><li>Net cash used in investing activities during the three months ended March 31, 2025 was -$1,250,000, compared to $0 for the prior year.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1673481/000164117225011865/form10-q.htm"></span></li><li>Net cash provided by financing activities was $697,022 for the three months ended March 31, 2025, compared to net cash provided of $700,000 for the three months ended March 31, 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1673481/000164117225011865/form10-q.htm"></span></li></ul><h3>Future Outlook and Strategy</h3><h4>Core Business Focus</h4><ul><li>The Company plans to relaunch its B2C Platform by mid-year 2025, initially in a limited number of US and International markets.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1673481/000164117225011865/form10-q.htm"></span></li><li>The Company acquired Spektrum LTD in March 2025, providing a platform designed to run in multiple international jurisdictions, with a launch scheduled for Q2 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1673481/000164117225011865/form10-q.htm"></span></li></ul><h4>Non-Core Business</h4><ul><li>The Company is moving forward with plans to monetize the Sports.com brand, including introducing an advertising-supported subscription model and creating original content through Sports.com Studios.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1673481/000164117225011865/form10-q.htm"></span></li></ul><h4>Priority</h4><ul><li>The Company believes that its cash on hand, along with future borrowings, will be sufficient to resume its core operations.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1673481/000164117225011865/form10-q.htm"></span></li></ul>

Translational Development Acquisition | 10-Q: FY2025 Q1 Revenue: USD 223.85 K